𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors

✍ Scribed by Jacob Lokich

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
103 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cisplatin and ifosfamide with either vin
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: The Institut Gustave Roussy experience
✍ Fadi Farhat; StΓ©phane Culine; Christine ThΓ©odore; Mohamed BΓ©kradda; Marie-JosΓ©e πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 476 KB πŸ‘ 2 views

## BACKGROUND. Approximately 30% of patients with metastatic germ cell tumors require salvage chemotherapy for recurrent or refractory disease after first-line treatment. The optimal salvage chemotherapy regimen remains to be determined. ## METHODS. Fifty-four patients with metastatic germ cell

The role of ifosfamide plus cisplatin-ba
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
✍ Robert J. Motzer; Karen Cooper; Nancy L. Geller; Dean F. Bajorin; Ethan Dmitrovs πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete